World Journal of Dentistry

Register      Login

VOLUME 13 , ISSUE S1 ( Supplementary Issue 1, 2022 ) > List of Articles

REVIEW ARTICLE

Management Protocols of Bleeding Disorders in Implant Dentistry: A Narrative Review

Nivya John, Manoj Shetty, Anuradha Roy, Karishma Ashok, Tarona Azem Subba

Keywords : Anticoagulants, Bleeding disorders, Dental implants, Dental surgery

Citation Information : John N, Shetty M, Roy A, Ashok K, Subba TA. Management Protocols of Bleeding Disorders in Implant Dentistry: A Narrative Review. World J Dent 2022; 13 (S1):S107-S112.

DOI: 10.5005/jp-journals-10015-2112

License: CC BY-NC 4.0

Published Online: 01-10-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Abstract

Aim: This review elaborates the significance of the knowledge of bleeding disorders in implant dentistry. Background: Bleeding disorders are the underlying cause of critical bleeding episodes in any type of dental surgery. It has been reported that bleeding disorders damage, or in certain subjects, make dental implant surgery complex. Implant dentists must perceive the ramifications of blood coagulopathies in the treatment of patients. It is of utmost importance for an implant clinician to identify the type of bleeding disorder and the signs and symptoms they present with. Review results: In this article, although there are limited case studies on implant surgeries in bleeding disorders, the common bleeding disorders and how they affect dental implant surgery have been discussed, along with the related postoperative complications, relevant surgical recommendations as well as practical suggestions for the clinicians. Conclusion and clinical significance: The management of the bleeding disorder should include careful planning with hematologists, a good knowledge of the hemostatic agents, and experience in administration of the same.


PDF Share
  1. Lambert FE, Waber HP, Susarla SM, et al. Descriptive analysis of implant and prosthodontic survival rates with fixed implant-supported rehabilitations in the edentulous maxilla. J Periodontal 2009;80(8):1220–1230. DOI: 10.1902/jop.2009.090109
  2. Clementini M, Morlupi A, Canullo L, et al. Success rate of dental implants inserted in the horizontal and vertical guided bone regenerated areas: a systematic review. Int J Oral Maxillofac Surg 2012;41(7):847–852. DOI: 10.1016/j.ijom.2012.03.016
  3. Retzepi M, Donos N. Guided bone regeneration: biological principle and therapeutic applications. Clin Oral Implants Res 2010;21(6): 567–576. DOI: 10.1111/j.1600-0501.2010.01922.x
  4. Donos N, Mardas N, Chadha V. Clinical outcomes of implants following lateral bone augmentation: systematic assessment of available options (barrier membranes, bone grafts, split osteotomy). J Clin Periodontol 2008;35(8):173–202. DOI: 10.1111/j.1600-051X.2008.01269.x
  5. Sonis ST, Fazio R, Setkowicz A, et al. Comparison of the nature and frequency of medical problems among patients in general, specialty and hospital dental practices. J Oral Med 1983;38(2):58–61. PMID: 6242748.
  6. McLundie AC, Watson WC, Kennedy GD. Medical status of patients undergoing dental care. An assessment. Br Dent J 1969;127(6): 265–271. PMID: 5258046.
  7. Alsaadi G, Quirynen M, Komarek A, et al. Impact of local and systemic factors on the incidence of oral implant failures, up to abutment connection. J Clin Periodontal 2007;34(7):610–617. DOI: 10.1111/j.1600-051X.2007.01077.x
  8. Liddelow G, Klineberg I. Patient-related risk factors for implant therapy. A critique of pertinent literature. Aust Dent J 2011;56(4): 417–426. DOI: 10.1111/j.1834-7819.2011.01367.x
  9. Beikler T, Flemming TF. Implants in the medically compromised patient. Crit Rev Oral Biol Med 2003;14(4):305–316. DOI: 10.1177/154411130301400407
  10. Diz P, Scully C, Sanz M. Dental implants in the medically compromised patient. J Dent 2013;41(3):195–206. DOI: 10.1016/j.jdent.2012.12.008
  11. Patton LL. Bleeding and clotting disorders. In: Burket's Oral Medicine: Diagnosis and Treatment. 10th ed. Hamilton (ON): BC Decker; 2003.
  12. Blinder MA. Bleeding disorders. [Web site of the Washington University School of Medicine]. Available from: http://hematology.im.wustl.edu/Conferences/presentations/blinder080604.ppt
  13. Golla K, Epstein JB, Cabay RJ. Liver disease: current perspectives on medical and dental management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;98(5):516–521. DOI: 10.1016/S1079210404006432
  14. Coumadin (Warfarin) Product Information. Princeton, NJ: Bristol-Myers Squibb Co.; 2011.
  15. Anglin R, Yuan Y, Moayyedi P, et al. Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: a systematic review and meta-analysis. Am J Gastroenterol 2014;109(6):811–819. DOI: 10.1038/ajg.2014.82
  16. Antman EM, Bennett JS, Daugherty A, et al. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation 2007;115(12):1634–1642. DOI: 10.1161/CIRCULATIONAHA.106.181424
  17. Natural Medicines Comprehensive Database. http://naturaldatabase.therapeuticresearch.com/home.aspx?cs=FACULTY&s=ND. Accessed February 2021.
  18. Meechan JG, Greenwood M. General medicine and surgery for dental practitioners. Part 9: haematology and patients with bleeding problems. Br Dent J 2003;195(6):305–310. DOI: 10.1038/sj.bdj.4810526
  19. National Hemophilia Foundation. What is a Bleeding Disorder? Available from: hemophilia.org/Bleeding-Disorders/What-is-a-Bleeding-Disorder. Accessed July 1, 2020.
  20. Cotman L, Bolt RJ. Medical evaluation of the pre-operative patient. Med Clin North Am 1979;63:6.
  21. Cuker A, Husseinzadeh H. Laboratory measurement of the anticoagulant activity of edoxaban: a systemic review. J Thromb Thrombolysis 2015;39(3):288–294. DOI: 10.1007/s11239-015-1185-7
  22. Yaedu RYF, de Almeida Barbosa Mello M, Silveira JSZ, et al. Edema Management in Oral and Maxillofacial Surgery [Online First]. IntechOpen; 2018. DOI: 10.5772/intechopen.80971. Available from: https://www.intechopen.com/online-first/edema-management-in-oral-and-maxillofacial-surgery. Accessed February 2021.
  23. Lambert PM, Morris HF, Ochi S. The influence of 0.12% chlorhexidine digluconate rinses on the incidence of infectious complications and implant success. J Oral Maxillofac Surg 1997;55(5):25–30. DOI: 10.1016/s0278-2391(16)31194-6
  24. Reich W, Kriwalsky MS, Wolf HH, et al. Bleeding complications after oral surgery in outpatients with compromised haemostasis: incidence and management. Oral Maxillofac Surg 2009;13(2):73–77. DOI: 10.1007/s10006-009-0154-8
  25. Balaguer-Martí J-C, Peñarrocha-Oltra D, Balaguer-Martínez J, et al. Immediate bleeding complications in dental implants: a systematic review. Med Oral Patol Oral Cir Bucal 2015;20(2):e231–e238. DOI: 10.4317/medoral.20203
  26. Fénelon M, Castet S, Fricain J-C, et al. Guided implant surgery to reduce morbidity in Von Willebrand disease patients: a case report. Open Dent J 2018;12:80–86. DOI: 10.2174/1874210601812010080
  27. Nazif M. Local anesthesia for patients with hemophilia. ASDC J Dent Child 1970;37(1):79–84. PMID: 4904493.
  28. Webster WP, Roberts HR, Penick GD. Dental care of patients with hereditary disorders of blood coagulation. Mod Treat 1968;5(1) 93–110. PMID: 4870182.
  29. Archer WH, Zubrow HJ. Fatal hemorrhage following regional anesthesia for operative dentistry in a hemophiliac. Oral Surg Oral Med Oral Pathol 1954;7(5):464–470. DOI: 10.1016/0030-4220(54)90003-1
  30. Leatherdale RAL. Respiratory obstruction in haemophilic patients. Br Med J 1960;1(5182):1316–1320. DOI: 10.1136/bmj.1.5182.1316
  31. Bogdan CJ, Strauss M, Ratnoff OD. Airway obstruction in hemophilia (factor VIII deficiency): a 28-year institutional review. Laryngoscope 1994;104(7):789–794. DOI: 10.1288/00005537-199407000-00002
  32. Arisan V, Karabuda CZ, Ozdemir T. Implant surgery using bone- and mucosa-supported stereolithographic guides in totally edentulous jaws: surgical and post-operative outcomes of computer-aided vs. standard techniques. Clin Oral Implants Res 2010;21(9):980–988. DOI: 10.1111/j.1600-0501.2010.01957.x
  33. Greenberg Martin S. Glick Michael: Burket's Oral Medicine. 11th ed. McGraw-Hill Medical; 2011.
  34. Rackoz M, Mazar A, Varon D, et al. Dental extractions in patients with bleeding disorders. The use of fibrin glue. Oral Surg Oral Med Oral Pathol 1993;75(3):280–282. DOI: 10.1016/0030-4220(93)90135-q
  35. Martinowitz U, Schulman S. Fibrin sealant in surgery of patients with hemorrhagic diathesis. Thromb Haemost 1995;74(1):486–492. PMID: 8578511.
  36. Martinowitz U, Schulman S, Horoszowski H, et al. Role of fibrin sealants in surgical procedures on patients with hemostatic disorders. Clin Orthop Relat Res 1996;(328):65–75. DOI: 10.1097/00003086-199607000-00013
  37. Pereira BM, Bortoto JB, Fraga GP. Topical hemostatic agents in surgery: review and prospects. Rev Col Bras Cir 2018;45(5):e1900. DOI: 10.1590/0100-6991e-20181900
  38. Vyas KS, Saha SP. Comparison of hemostatic agents used in vascular surgery. Expert Opin Biol Ther 2013;13(12):1663–1672. DOI: 10.1517/14712598.2013.848193
  39. Gupta A, Epstein JB, Cabay R. Bleeding disorders of importance in dental care and related patient management. J Can Dent Assoc 2007;73(1):77–83. PMID: 17295950.
  40. Epping L, Miesbach W, Nickles K, et al. Is gingival bleeding a symptom of type 2 and 3 von Willebrand disease? PLoS One 2018;13(1):e0191291. DOI: 10.1371/journal.pone.0191291
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.